Annual report [Section 13 and 15(d), not S-K Item 405]

Income Taxes (Tables)

v3.26.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income taxes  
Schedule of Components of Income Tax Expense (Benefit)

Year Ended December 31, 

($ in thousands)

  ​ ​ ​

2025

  ​ ​ ​

2024

Current

  ​

  ​

Federal

$

$

3

State

 

(498)

 

140

Deferred

 

 

Federal

 

(99)

 

136

State

 

(23)

 

33

Total

$

(620)

$

312

Schedule of Deferred Tax Assets and Liabilities

As of December 31, 

($ in thousands)

2025

2024

Deferred tax assets:

  ​ ​ ​

  ​

  ​ ​ ​

  ​

Net operating loss carryforwards

$

201,473

$

232,740

Amortization of license fees

 

17,303

 

29,421

Amortization of in-process R&D

 

180

 

242

Stock compensation

 

6,398

 

12,773

Lease liability

 

3,534

 

4,763

Accruals and reserves

 

4,228

 

3,676

Tax credits

 

34,127

 

40,623

Startup costs

 

10

 

30

Unrealized gain/loss on investments

 

64

 

48

Section 174 R&D expenditure capitalization

22,937

53,510

State taxes

27

(70)

Business interest limitation

4,046

4,154

Reserve on Sales Return, Discount and Bad Debt

 

4,636

 

2,714

Total deferred tax assets

 

298,963

 

384,624

Less: valuation allowance

 

(294,081)

 

(377,965)

Net deferred tax assets

$

4,882

$

6,659

Deferred tax liabilities:

 

  ​

 

  ​

Debt issuance costs

(42)

Right of use asset

(2,937)

(3,800)

Basis in subsidiary

 

(1,998)

 

(3,219)

Other

 

(227)

 

Total deferred tax liabilities, net

$

(280)

$

(402)

Schedule of Effective Income Tax Rate Reconciliation

Year Ended December 31, 

2025

($ in thousands)

Amount

Percentage

U.S. federal statutory tax rate

$

(7,020)

21.0

%

State and local income taxes, net of federal income tax effect1

 

1,525

 

(4.6)

%

Tax credits

 

(325)

 

1.0

%

Change in valuation allowance

 

(75,103)

 

224.7

%

Non-deductible items:

 

 

Share-based compensation

 

5,206

 

(15.6)

%

Transaction costs

 

3,106

 

(9.3)

%

Other

 

(191)

 

0.6

%

Changes in unrecognized tax benefits

 

(2,073)

 

6.2

%

Other Adjustments:

Sale of subsidiaries2

75,159

(224.8)

%

Sale of IP

(1,515)

4.5

%

Other

 

611

 

(1.8)

%

Provision for income taxes and effective income tax rate

$

(620)

1.9

%

Note 1:

During the year ended December 31, 2025, state taxes in New York, New York City, Massachusetts, and Florida comprised greater than 50% of the tax effect in this category.

Note 2:

The Sale of Subsidiaries is mostly driven by the write-off of Checkpoint’s tax attributes and other deferred tax assets due to the sale of the subsidiary in 2025. There is an offsetting impact within the Change in Valuation Allowance as the deferred tax assets maintain a full valuation allowance.

Year Ended December 31, 

 

  ​ ​ ​

2024

 

Percentage of pre-tax income:

  ​

U.S. federal statutory income tax rate

 

21.0

%  

State taxes, net of federal benefit

 

4.2

%  

Credits

 

1.8

%  

Non-deductible items

 

(0.5)

%  

Provision to return

 

(3.7)

%  

Stock based compensation shortfall

 

(0.4)

%  

Change in state rate

 

(8.2)

%  

Change in valuation allowance

 

(9.6)

%  

Change in subsidiary basis

 

(1.0)

%  

Adjustment for warrants

(0.1)

%  

Section 162(m) compensation disallowance

(3.5)

%  

Other

 

(0.2)

%  

Effective income tax rate

 

(0.2)

%  

Schedule of unrecognized tax benefits

Year Ended December 31, 

($ in thousands)

2025

Balance at December 31, 2024

$

3,200

Reductions for lapse in statute of limitations

(2,233)

Balance at December 31, 2025

$

967

Schedule of income taxes paid (net of refunds received) by jurisdiction,

Year Ended December 31, 

($ in thousands)

2025

Federal

$

1

State

Texas

45

Other

3

Total net payments

$

49